Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-12-4
pubmed:abstractText
B7H3 immunogene therapy is able to completely eradicate tumors when combined with an anti-vascular agent. The aim of this study was to determine whether vasostatin, a potent anti-angiogenic agent, could synergize with B7H3-mediated immunotherapy to combat hepatocellular carcinoma (HCC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
98-106
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17109987-Animals, pubmed-meshheading:17109987-Antigens, CD80, pubmed-meshheading:17109987-B7 Antigens, pubmed-meshheading:17109987-Base Sequence, pubmed-meshheading:17109987-Calreticulin, pubmed-meshheading:17109987-Cattle, pubmed-meshheading:17109987-Cell Line, pubmed-meshheading:17109987-Cell Proliferation, pubmed-meshheading:17109987-Gene Expression, pubmed-meshheading:17109987-Gene Therapy, pubmed-meshheading:17109987-Immunotherapy, pubmed-meshheading:17109987-Liver Neoplasms, Experimental, pubmed-meshheading:17109987-Male, pubmed-meshheading:17109987-Mice, pubmed-meshheading:17109987-Mice, Inbred BALB C, pubmed-meshheading:17109987-Neovascularization, Pathologic, pubmed-meshheading:17109987-Peptide Fragments, pubmed-meshheading:17109987-Plasmids, pubmed-meshheading:17109987-Recombinant Proteins, pubmed-meshheading:17109987-Transfection
pubmed:year
2007
pubmed:articleTitle
Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy.
pubmed:affiliation
The Hepatosplenic Surgery Center of Heilongjiang Province/Department of General Surgery, The First Clinical College of Harbin Medical University, Harbin 150001, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't